Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 8 | 4 | POLYMER SCIENCE//CHEMISTRY, PHYSICAL//MATERIALS SCIENCE, MULTIDISCIPLINARY | 1554940 |
| 88 | 3 | INTERNATIONAL JOURNAL OF PHARMACEUTICS//DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY//CHITOSAN | 80849 |
| 1228 | 2 | LIPOSOMES//NIOSOMES//ETHOSOMES | 9338 |
| 27625 | 1 | NANOART//MAGNETOELECTRIC NANOPARTICLES//CELL MEDIATED DRUG DELIVERY | 245 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | NANOART | authKW | 900480 | 3% | 100% | 7 |
| 2 | MAGNETOELECTRIC NANOPARTICLES | authKW | 385920 | 1% | 100% | 3 |
| 3 | CELL MEDIATED DRUG DELIVERY | authKW | 350178 | 3% | 39% | 7 |
| 4 | NANOFORMULATED ANTIRETROVIRAL THERAPY | authKW | 289438 | 1% | 75% | 3 |
| 5 | PHARMACOL EXPT NEUROSCI | address | 286400 | 16% | 6% | 39 |
| 6 | ANTIRETROVIRAL DRUG TARGETING | authKW | 257280 | 1% | 100% | 2 |
| 7 | LIPID ASSOCIATED DRUG | authKW | 257280 | 1% | 100% | 2 |
| 8 | LONG ACTING NANOFORMULATED ANTIRETROVIRAL THERAPY | authKW | 257280 | 1% | 100% | 2 |
| 9 | PROTEASE MACAQUE MODEL | authKW | 257280 | 1% | 100% | 2 |
| 10 | HUMAN IMMUNODEFICIENCY VIRUS TYPE ONE | authKW | 231549 | 1% | 60% | 3 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Nanoscience & Nanotechnology | 1239 | 25% | 0% | 61 |
| 2 | Pharmacology & Pharmacy | 1124 | 40% | 0% | 98 |
| 3 | Materials Science, Biomaterials | 553 | 8% | 0% | 20 |
| 4 | Virology | 446 | 11% | 0% | 26 |
| 5 | Infectious Diseases | 276 | 11% | 0% | 26 |
| 6 | Biotechnology & Applied Microbiology | 141 | 11% | 0% | 28 |
| 7 | Immunology | 78 | 10% | 0% | 25 |
| 8 | Medicine, Research & Experimental | 67 | 7% | 0% | 18 |
| 9 | Chemistry, Multidisciplinary | 42 | 11% | 0% | 28 |
| 10 | Biophysics | 41 | 6% | 0% | 14 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | PHARMACOL EXPT NEUROSCI | 286400 | 16% | 6% | 39 |
| 2 | PERSONALIZED NANOMED IMMUNOL | 231549 | 1% | 60% | 3 |
| 3 | ACCELERATING INNOVAT IMPACT | 128640 | 0% | 100% | 1 |
| 4 | AICA S | 128640 | 0% | 100% | 1 |
| 5 | AU PK | 128640 | 0% | 100% | 1 |
| 6 | BIOQUIMICAY MED MOL | 128640 | 0% | 100% | 1 |
| 7 | COUNCIL SCI IND MAT SCI MFG | 128640 | 0% | 100% | 1 |
| 8 | EA PHARMACOL MEDICAMENTS ANTIINFECT 3809 | 128640 | 0% | 100% | 1 |
| 9 | GUWAHATI BIOTECH PK | 128640 | 0% | 100% | 1 |
| 10 | JOHN T MACDONALD FDN BIOMED NANOTECHNOL | 128640 | 0% | 100% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | NANOMEDICINE | 27525 | 7% | 1% | 17 |
| 2 | INTERNATIONAL JOURNAL OF NANOMEDICINE | 6115 | 5% | 0% | 13 |
| 3 | DRUG DELIVERY AND TRANSLATIONAL RESEARCH | 3379 | 1% | 1% | 3 |
| 4 | NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE | 3132 | 2% | 0% | 6 |
| 5 | JOURNAL OF NANOBIOTECHNOLOGY | 2584 | 1% | 1% | 3 |
| 6 | ADVANCED DRUG DELIVERY REVIEWS | 1693 | 2% | 0% | 6 |
| 7 | CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS | 1537 | 1% | 1% | 2 |
| 8 | DRUG DELIVERY | 1499 | 2% | 0% | 4 |
| 9 | COLLOIDS AND SURFACES B-BIOINTERFACES | 1397 | 4% | 0% | 9 |
| 10 | CURRENT HIV RESEARCH | 1363 | 1% | 0% | 3 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |